Sentry Investment Management LLC decreased its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 14.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 861 shares of the technology company’s stock after selling 140 shares during the period. Sentry Investment Management LLC’s holdings in AMETEK were worth $155,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in AME. MassMutual Private Wealth & Trust FSB lifted its stake in AMETEK by 4.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,450 shares of the technology company’s stock valued at $261,000 after acquiring an additional 63 shares during the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of AMETEK by 42.9% during the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock worth $42,000 after buying an additional 70 shares during the last quarter. AlphaMark Advisors LLC lifted its stake in shares of AMETEK by 2.1% during the 4th quarter. AlphaMark Advisors LLC now owns 3,348 shares of the technology company’s stock worth $604,000 after buying an additional 70 shares during the last quarter. Quotient Wealth Partners LLC lifted its stake in shares of AMETEK by 3.9% during the 4th quarter. Quotient Wealth Partners LLC now owns 1,843 shares of the technology company’s stock worth $332,000 after buying an additional 70 shares during the last quarter. Finally, Howard Capital Management Inc. lifted its stake in shares of AMETEK by 5.0% during the 4th quarter. Howard Capital Management Inc. now owns 1,501 shares of the technology company’s stock worth $271,000 after buying an additional 72 shares during the last quarter. Institutional investors own 87.43% of the company’s stock.
AMETEK Price Performance
AME stock opened at $188.12 on Thursday. The company has a quick ratio of 0.75, a current ratio of 1.24 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a 12 month low of $149.03 and a 12 month high of $198.33. The firm has a market cap of $43.51 billion, a P/E ratio of 31.72, a P/E/G ratio of 2.73 and a beta of 1.16. The company’s 50-day moving average price is $183.03 and its two-hundred day moving average price is $178.81.
AMETEK announced that its board has authorized a share repurchase plan on Friday, February 7th that authorizes the company to repurchase $1.25 billion in outstanding shares. This repurchase authorization authorizes the technology company to repurchase up to 2.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its stock is undervalued.
AMETEK Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be paid a $0.31 dividend. This is an increase from AMETEK’s previous quarterly dividend of $0.28. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Friday, March 14th. AMETEK’s dividend payout ratio (DPR) is presently 18.89%.
Analyst Upgrades and Downgrades
AME has been the subject of a number of research reports. KeyCorp raised their target price on shares of AMETEK from $205.00 to $215.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. StockNews.com upgraded shares of AMETEK from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Bank of America upgraded shares of AMETEK from a “neutral” rating to a “buy” rating and raised their target price for the stock from $195.00 to $225.00 in a research note on Monday, December 16th. Robert W. Baird cut their target price on shares of AMETEK from $200.00 to $197.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Finally, Truist Financial raised their price target on shares of AMETEK from $221.00 to $222.00 and gave the stock a “buy” rating in a research report on Thursday, January 16th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $204.67.
Check Out Our Latest Stock Analysis on AMETEK
AMETEK Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Further Reading
- Five stocks we like better than AMETEK
- Using the MarketBeat Stock Split Calculator
- Buffett’s on the Sidelines – Should You Follow?
- There Are Different Types of Stock To Invest In
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Compound Interest and Why It Matters When Investing
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.